Clinical trial
Prospective and Controlled Glucocerebrosidase-related Parkinson's Disease Evaluation of Non Motor Symptoms (PROGENS-PD)
NCT06451419 is registered in ClinicalTrials.gov with Juan Pablo Romero. MD, PhD as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Prospective and Controlled Glucocerebrosidase-related Parkinson's Disease Evaluation of Non Motor Symptoms (PROGENS-PD)
- Lead sponsor
- Juan Pablo Romero. MD, PhD
- Phase
- Observational
- Overall status
- Enrolling by invitation
- Start date
- July 1, 2024
- Completion date
- August 31, 2026
- Enrollment
- 40 (estimated)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.